Cycclone Inc. (CYCL)
| Market Cap | 1.43M -33.8% |
| Revenue (ttm) | 20.95M +45.2% |
| Net Income | 6.41M +96.1% |
| EPS | 0.21 +109.7% |
| Shares Out | 40.98M |
| PE Ratio | 0.16 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 400 |
| Open | 0.0350 |
| Previous Close | n/a |
| Day's Range | 0.0350 - 0.0350 |
| 52-Week Range | 0.0065 - 0.0670 |
| Beta | 1.90 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About Cycclone
Cycclone Inc. focuses on inventing, designing, and developing magnets as the driving force. The company was formerly known as China Dasheng Biotechnology Co. and changed its name to Cycclone Inc. in May 2025. Cycclone Inc. was incorporated in 2007 and is based in Arundel, Australia. [Read more]
News
Cycclone, Inc. Announces Agreement in Principle for the Acquisition of AI Robotics Company
NEW YORK CITY, NY / ACCESS Newswire / June 13, 2026 / Cycclone, Inc. (OTCID:CYCL) today acknowledges reaching an agreement in principle to acquire an AI Robotics design, develop and manufacturing comp...
CDBT Registers Magistrates Court of Queensland Judgments against Kenneth Maciora / Empire Relations Group
ARUNDEL, AUSTRALIA / ACCESSWIRE / December 16, 2023 / China Dasheng Biotechnology Co. (OTC Pink: CDBT) advises that it has been issued 2 Judgements, $17,129.13 and $17,066.59 in its favor against Kenn...
CDBT - Terminates Consulting Agreement with Kenneth Maciora / Empire Relations Group
ARUNDEL, AUSTRALIA / ACCESSWIRE / October 9, 2023 / China Dasheng Biotechnology Co. (OTC PINK:CDBT) advisors that the company has terminated the China Dasheng Biotechnology Co. Consulting Agreement wi...
CDBT - Cycclone Magnetic Engines
China Dasheng Biotechnology Co. OTC-CDBT (to be renamed Cycclone Magnetic Engines, Inc.) ARUNDEL, QUEENSLAND, AUSTRALIA / ACCESSWIRE / August 29, 2023 / China Dasheng Biotechnology Co. (OTC PINK:CDBT)...
CDBT'S Transport Operations Expand
ARUNDEL, AUSTRALIA / ACCESSWIRE / June 5, 2023 / China Dasheng Biotechnology Co. (OTC PINK:CDBT) as disclosed, holds transport assets and operations in their normal course of business. CDBT is a major...
CDBT Enters Agreement to Acquire Cycclone Magnetic Engines, Inc., the Founding Company of the Magnetic Engine Project
ARUNDEL, AUSTRALIA / ACCESSWIRE / April 24, 2023 / China Dasheng Biotechnology Co. (OTC PINK:CDBT) today signed a Share Exchange Agreement for the purchase of all of the outstanding shares of Cycclone...
Cycclone Magnetic Engines Acknowledges Embezzlement Allegations Against Cameron James Smith in their Transport Holdings
ARUNDEL QUEENSLAND, AUSTRALIA / ACCESSWIRE / April 20, 2023 / China Dasheng Biotechnology Co. (OTC PINK:CDBT) as disclosed, holds transport assets and operations in their normal course of business. In...
Cycclone Magnetic Engines Enters Work Order to Produce and Fit Y9XM Engine
ARUNDEL QUEENSLAND, AUSTRALIA / ACCESSWIRE / February 20, 2023 / China Dasheng Biotechnology Co. (OTC PINK:CDBT) through controlled subsidiary Cycclone & Y Engine Developments Pty Ltd has signed a wor...
CDBT Cycclone Magnetic Engines Acknowledges GBL Article
Cycclone Magnetic Engines acknowledges published article in Global Business Leaders Magazine. ARUNDEL, QUEENSLAND, AUSTRALIA / ACCESSWIRE / February 17, 2023 / China Dasheng Biotechnology Co. (OTC PIN...
Cycclone Magnetic Engines Limited Opens Component Development Facility
ARUNDEL QUEENSLAND, AUSTRALIA / ACCESSWIRE / January 23, 2023 / China Dasheng Biotechnology Co. (OTC PINK:CDBT) to be renamed Cycclone Magnetic Engine Developments, Inc., has leased 2 industrial prope...
New CEO of China Dasheng Biotechnology Co. Explains the Complexities of Working in “Unproven Technologies”
ARUNDEL QUEENSLAND, AUSTRALIA / ACCESSWIRE / November 15, 2022 / Arundel, Queensland, Australia, China Dasheng Biotechnology Co. (OTC PINK:CDBT) to be renamed Cycclone Magnetic Engine Developments, In...